Skip to main content
. 2011 Jun 15;17(17-18):2221–2230. doi: 10.1089/ten.tea.2011.0131

Table 3.

Number of Cellular Therapy Transplants for Novel Cellular Therapies in Europe 2009 Sorted by Delivery Mode

 
Cell delivery mode
Indications i.v. Intraorgan Membrane/gel 3D Total
Cardiovascular
 Peripheral artery disease 3 53     56
 Cardiomyopathy   12     12
 Heart failure   33     33
 Myocardial ischemia 47 64     111
 Bypass graft   16     16
 Valve replacement
 Ulcer     150   150
 Other 23       23
Musculoskeletal
 Bone repair (maxillofacial)   1   1 2
 Bone repair (orthopedics)   22   46 68
 Osteogenesis imperfecta   1     1
 Cartilage repair   60 11 20 91
 Muscle repair
 Tendon/ligament   5     5
 Reconstructive surgery 1       1
 Other   17     17
Neurological
 Parkinson's
 Peripheral nerve regeneration
 Other 3 13     16
Epithelial
 Skin reconstruction     51    
 Cornea repair     27   27
 Organ failure   10     10
 Diabetes
 Liver insufficiency 2       2
 Other
Autoimmune
 Neurological   80     80
 Rheumatological 2       2
 Gastrointestinal 5        
 Other 13 3     16
Graft vs. host disease 19       19
Total 118 390 239 67 814

Data only from extended questionnaire.

i.v., intravenous.